Application ID

Milestone

Created on

Change

Initials

102639414

MAA approval

01.09.2021

New

MW/SS

102665010

Type II (immunogenicity), Type IB (contraception requirements) and Type IB (stability of diluted product) approval

12.01.2022

New

SSE

102679334

ATC code update

12.05.2022

New

SSE

Pending

Type II (granuloma)

07.08.2024

New

CS

Pending

Response to Preapproval Type II variation (Granuloma)

05.12.2024

Supplemental

RG